These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 21743005)
1. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Kociol RD; Horton JR; Fonarow GC; Reyes EM; Shaw LK; O'Connor CM; Felker GM; Hernandez AF Circ Heart Fail; 2011 Sep; 4(5):628-36. PubMed ID: 21743005 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure. Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268 [TBL] [Abstract][Full Text] [Related]
3. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure. Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284 [TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure. Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779 [TBL] [Abstract][Full Text] [Related]
5. Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction. Omar HR; Guglin M Int J Cardiol; 2016 Oct; 221():1116-22. PubMed ID: 27467969 [TBL] [Abstract][Full Text] [Related]
6. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). Cleland JGF; Teerlink JR; Davison BA; Shoaib A; Metra M; Senger S; Milo O; Cotter G; Bourge RC; Parker JD; Jondeau G; Krum H; O'Connor CM; Torre-Amione G; van Veldhuisen DJ; McMurray JJV; Eur J Heart Fail; 2017 Jun; 19(6):739-747. PubMed ID: 28296139 [TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes. Flint KM; Allen LA; Pham M; Heidenreich PA J Am Heart Assoc; 2014 Jun; 3(3):e000806. PubMed ID: 24922626 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions. Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T; Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996 [TBL] [Abstract][Full Text] [Related]
9. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148 [TBL] [Abstract][Full Text] [Related]
10. GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome. Kosum P; Siranart N; Mattanapojanat N; Phutinart S; Kongruttanachok N; Sinphurmsukskul S; Siwamogsatham S; Puwanant S; Ariyachaipanich A BMC Cardiovasc Disord; 2024 Mar; 24(1):151. PubMed ID: 38475710 [TBL] [Abstract][Full Text] [Related]
11. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry. Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182 [TBL] [Abstract][Full Text] [Related]
12. Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients. Cabassi A; de Champlain J; Maggiore U; Parenti E; Coghi P; Vicini V; Tedeschi S; Cremaschi E; Binno S; Rocco R; Bonali S; Bianconcini M; Guerra C; Folesani G; Montanari A; Regolisti G; Fiaccadori E Int J Cardiol; 2013 Oct; 168(4):3334-9. PubMed ID: 23623341 [TBL] [Abstract][Full Text] [Related]
13. Improvements of predictive power of B-type natriuretic peptide on admission by mathematically estimating its discharge levels in hospitalised patients with acute heart failure. Anegawa E; Takahama H; Nishimura K; Onozuka D; Irie Y; Moriuchi K; Amano M; Okada A; Amaki M; Kanzaki H; Noguchi T; Kusano K; Yasuda S; Izumi C Open Heart; 2021 May; 8(1):. PubMed ID: 34001654 [TBL] [Abstract][Full Text] [Related]
14. Acute systolic heart failure with normal admission BNP: clinical features and outcomes. Omar HR; Guglin M Int J Cardiol; 2017 Apr; 232():324-329. PubMed ID: 28094130 [TBL] [Abstract][Full Text] [Related]
15. Risk Prediction in Transition: MAGGIC Score Performance at Discharge and Incremental Utility of Natriuretic Peptides. Michaels A; Aurora L; Peterson E; Liu B; Pinto YM; Sabbah HN; Williams K; Lanfear DE J Card Fail; 2020 Jan; 26(1):52-60. PubMed ID: 31751788 [TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918 [TBL] [Abstract][Full Text] [Related]
17. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population. Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439 [TBL] [Abstract][Full Text] [Related]
18. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. Logeart D; Thabut G; Jourdain P; Chavelas C; Beyne P; Beauvais F; Bouvier E; Solal AC J Am Coll Cardiol; 2004 Feb; 43(4):635-41. PubMed ID: 14975475 [TBL] [Abstract][Full Text] [Related]